Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 3

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 3
---
the sale of securities offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use
such funds to effectively implement our business plan. We will bear all costs associated with the offering. See “Plan of Distribution”
on page 34 of this prospectus for more information regarding these arrangements

We intend to use the proceeds from this offering
for general corporate purposes, including working capital. See “Use of Proceeds.”

On February 24, 2025,
we effected a reverse stock split of our common stock at a ratio of 1-for-5. Unless otherwise indicated, all financial information, share
numbers, option numbers, warrant numbers, other derivative security numbers and exercise prices appearing in this registration statement
have been adjusted to give effect to the reverse stock split.

Investing in our securities involves a high degree of risk. See “ Risk Factors” beginning on page 19 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

We are an “emerging growth company”
and a “smaller reporting company” as defined in the Jumpstart Our Business Startups Act of 2012, and have elected to comply
with certain reduced public company reporting requirements.

|                                     |     | Per Share and 
 Accompanying  
 Warrants      |        |     | Per Pre-Funded 
 Warrant and    
 Accompanying   
 Warrants       |        |     | Total |              |
|:------------------------------------|:----|:--------------|-------:|:----|:---------------|-------:|:----|:------|-------------:|
| Public offering price               |     | $             |   1.90 |     | $              |  1.899 |     | $     | 4,999,119.94 |
| Placement agent fees(1)             |     | $             | 0.1425 |     | $              | 0.1425 |     | $     |   374,999.87 |
| Proceeds, before expenses, to us(2) |     | $             | 1.7575 |     | $              | 1.7565 |     | $     | 4,624,120.07